BIO-GATE AG O.N./ DE000BGAG981 /
10/11/2024 5:36:07 PM | Chg. +0.055 | Volume | Bid10/11/2024 | Ask10/11/2024 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
0.850EUR | +6.92% | 2,209 Turnover: 1,768.865 |
-Bid Size: - | -Ask Size: - | 6.15 mill.EUR | 0.00% | - |
Fundamentals
FY 2021 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | -0.07 EUR | -41.67% |
EPS Diluted: | -0.07 EUR | -41.67% |
Revenues per Share: | 0.81 EUR | 9.22% |
Book Value per Share: | 0.50 EUR | 113.37% |
Cash Flow per Share: | -0.08 EUR | -10.16% |
Dividend per Share: | 0.00 EUR | - |
Total | in mill. | |
Revenues: | 6.20 EUR | 21.57% |
Net Income: | -0.50 EUR | -37.50% |
Operating Cash Flow: | -0.60 EUR | - |
Cash and Cash Equivalents: | 2.00 EUR | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | - | - |
P/S Ratio: | 0.99 | 4.78 |
P/BV ratio: | 1.62 | 7.80 |
P/CF Ratio: | -10.25 | -49.40 |
PEG: | 0.28 | - |
Earnings Yield: | -8.70% | -1.80% |
Dividend Yield: | 0.00% | 0.00% |
Market Capitalization | ||
Market Capitalization: | 6.15 mill. EUR | 29.64 mill. EUR |
Free Float Market Cap.: | 1.13 mill. EUR | 5.42 mill. EUR |
Market Cap. / Employee: | 170,816.5278 EUR | 823,314.4444 EUR |
Shares Outstanding: | 7.64 mill. |
Profitability
Gross Profit Margin: | 62.90% |
EBIT Margin: | -8.06% |
Net Profit Margin: | -8.06% |
Return on Equity: | -13.16% |
Return on Assets: | -9.62% |
Financial Strength
Liquidity I / Cash Ratio: | - |
Liquidity II / Quick Ratio: | - |
Liquidity III / Current Ratio: | - |
Debt / Equity Ratio: | 36.84% |
Dynam. Debt / Equity Ratio: | -233.33% |
Efficiency
Employees: | 36 |
Personal Expenses / Employee: | 69,444.44 EUR |
Revenues / Employee: | 172,222.22 EUR |
Net Income / Employee: | -13,888.89 EUR |
Total Assets / Employee: | 144,444.44 EUR |
* Fiscal Year End: | 12/31/2021 |
Accounting Standard: | HGB |
Currency: | EUR |